The updated Cochrane review 2014 on GnRH agonist trigger: Repeating the same errors

Reproductive BioMedicine Online

Volumn 30, Issue 6, 2015, Pages 563-565

  Kol, Shahar ^a   Humaidan, Peter ^b   Alsbjerg, Birgit ^b   Engmann, Lawrence ^c   Benadiva, Claudio ^c   García Velasco, Juan A ^d   Fatemi, Human ^e   Andersen, Claus Yding ^f  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d University Madrid   (Spain)

^e NOVA IVI Fertility Center   (United Arab Emirates)

^f Rigshospitalet   (Denmark)

Author keywords

Cochrane review; GnRHa triggering; luteal support; meta analysis

Indexed keywords

GONADORELIN AGONIST; GONADORELIN;

ANALYTICAL ERROR; COCHRANE LIBRARY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PREGNANCY; REVIEW; SYSTEMATIC REVIEW (TOPIC); AGONISTS; FEMALE; PREGNANCY RATE;

FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; PREGNANCY; PREGNANCY RATE;

EID: 84930924108     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2015.02.009     Document Type: Note

References (23)

1. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, K. Diedrich, S. Bustion, E. Loumaye, and B.C. Fauser Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J. Clin. Endocrinol. Metab 88 2003 4186 4192
2. D. Bodri, J.J. Guillen, M. Trullenque, K. Schwenn, C. Esteve, and O. Coll Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study Fertil. Steril 93 2010 2418 2420
3. M. Cerrillo, S. Rodriguez, M. Mayoral, A. Pacheco, J. Martinez-Salazar, and J.A. Garcia-Velasco Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction Fertil. Steril 91 2009 1526 1528
4. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil. Steril 89 2008 84 91
5. J. Evans, and L.A. Salamonsen Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity Hum. Reprod 28 2013 1610 1619
6. G. Griesinger, E.M. Kolibianakis, E.G. Papanikolaou, K. Diedrich, S.A. Van, P. Devroey, B.H. Ejdrup, and P. Humaidan Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles Fertil. Steril 88 2007 616 621
7. E.R. Hernandez, J.L. Gomez-Palomares, and E. Ricciarelli No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles Fertil. Steril 91 2009 1358 1361
8. P. Humaidan, and N.P. Polyzos (Meta)analyze this: systematic reviews might lose credibility Nat. Med 18 2012 1321
9. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grøndahl, L. Westergaard, and C.Y. Andersen GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod 20 2005 1213 1220
10. P. Humaidan, S. Kol, L. Engmann, C. Benadiva, E.G. Papanikolaou, C.Y. Andersen Copenhagen GnRH Agonist Triggering Workshop Group Should Cochrane reviews be performed during the development of new concepts? Hum. Reprod 27 2010 6 8
11. P. Humaidan, L.G. Westergaard, A.L. Mikkelsen, M. Fukuda, and A.C. Yding Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin Fertil. Steril 95 2011 2034 2038
12. P. Humaidan, N.P. Polyzos, B. Alsbjerg, K. Erb, A.L. Mikkelsen, H.O. Elbaek, E.G. Papanikolaou, and C.Y. Andersen GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients Hum. Reprod 28 2013 2511 2521
13. S. Kol, and P. Humaidan GnRH agonist triggering: recent developments Reprod. Biomed. Online 26 2013 226 230
14. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum. Reprod 20 2005 2887 2892
15. O. Nevo, T. Eldar-Geva, S. Kol, and J. Itskovitz-Eldor Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin Fertil. Steril 79 2003 1123 1128
16. K. Oktay, I. Turkcuoglu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod. Biomed. Online 20 2010 783 788
17. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, C. Hudson, and S. Thomas Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders Fertil. Steril 96 2011 516 518
18. C. Simon, and J. Bellver Scratching beneath 'The Scratching Case': systematic reviews and meta-analyses, the back door for evidence-based medicine Hum. Reprod 29 2014 1618 1621
19. C. Simon, E. Bosch, and J. Bellver Reply: endometrial scratching for women with repeated implantation failure Hum. Reprod 29 2014 2856 2857
20. D. Valbuena, J. Martin, J.L. de Pablo, J. Remohi, A. Pellicer, and C. Simon Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo Fertil. Steril 76 2001 962 968
21. C. Yding Andersen, and K. Vilbour Andersen Improving the luteal phase after ovarian stimulation: reviewing new options Reprod. Biomed. Online 28 2014 552 559
22. M.A. Youssef, F. Van der Veen, H.G. Al-Inany, G. Griesinger, M.H. Mochtar, and M. van Wely Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst. Rev 11 2010 10.1002/14651858.CD008046.pub2 CD008046
23. M.A. Youssef, F. Van der Veen, H.G. Al-Inany, M.H. Mochtar, G. Griesinger, M. Nagi Mohesen, I. Aboulfoutouh, and M. van Wely Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology Cochrane Database Syst. Rev 10 2014 10.1002/14651858.CD008046.pub4 CD008046